Line 46: | Line 46: | ||
<br> | <br> | ||
<ol> | <ol> | ||
− | <li><h4>We wanted to first learn what were the issues associated with the koi fish industry and more specifically to see what a potential problems exists that could be solved, or at least improved, with synthetic biology concepts. This was our <b>generating ideas | + | <li><h4>We wanted to first learn what were the issues associated with the koi fish industry and more specifically to see what a potential problems exists that could be solved, or at least improved, with synthetic biology concepts. This was our <b>generating ideas and <b>identifying problems</b> part of the engineering design process.</h4></li> |
− | <li><h4>We then wanted advice on the early stages of our genetically engineered systems. Here we sought academic experts that have worked on the health of fish in aquaculture and precisely the health and breeding of Koi. The ideas generated we had at this stage were based on discussion | + | <li><h4>We then wanted advice on the early stages of our genetically engineered systems. Here we sought academic experts that have worked on the health of fish in aquaculture and precisely the health and breeding of Koi. The ideas generated we had at this stage were based on discussion among ourselves and from a review of the associated literature. We were able to discuss in detail our <b>potential solutions</b> with professors and bring back more ideas for the <b>refinement</b> stage of our project design.</h4></li> |
<li><h4>Once we developed our idea and design to an advanced stage we wanted to seek out people within the fish feed and drug industry, as these people are also experts in the final product for therapeutics relating to aquaculture. At this stage we had identified <b>new problems</b> that needed overcoming and got valuable insight from these people on the methods used to deliver such medicines and biomolecules to fish. We also gained insight into the business side of things and how we could possibly eventually develop our idea into a marketable product should any trails we performed prove successful.</h4></li> | <li><h4>Once we developed our idea and design to an advanced stage we wanted to seek out people within the fish feed and drug industry, as these people are also experts in the final product for therapeutics relating to aquaculture. At this stage we had identified <b>new problems</b> that needed overcoming and got valuable insight from these people on the methods used to deliver such medicines and biomolecules to fish. We also gained insight into the business side of things and how we could possibly eventually develop our idea into a marketable product should any trails we performed prove successful.</h4></li> | ||
</ol> | </ol> |
Revision as of 23:16, 21 October 2019
Human Practice
Introduction
Our project’s focus was on the development of engineered bacterial strains which could act as vaccine delivery systems by expressing recombinant genes. Our long term goal would be to have a positive impact of on the aquaculture and fisheries industries, more specifically, the high end and mid level ornamental fish industry which breed varieties of koi fish (Cyprinus rubrofuscus). Our final engineered designs we worked so hard on were designed to be capable of providing these high value fish varieties immunity against the Cyprinid herpes virus-3, which cases the high mortality rate disease Koi herpesvirus disease (KHVD).
As always the design of a genetically engineered system requires many revisions, multiple identification of new problems, and several development of potential solutions all of which needed to be informed by good science and have logical reasoning for pursuing. In this sense, each stage of our project since the early team meetings of our BioBuilder club have been informed by the individuals and organizations we sought out and contacted, in order to ensure we had a safe, consequential, interesting, and scientifically sound project. This section outlines our efforts in that endeavor.
The goals of our integrated Human Practices work can be summarized in the following points:
We wanted to first learn what were the issues associated with the koi fish industry and more specifically to see what a potential problems exists that could be solved, or at least improved, with synthetic biology concepts. This was our generating ideas and identifying problems part of the engineering design process.
We then wanted advice on the early stages of our genetically engineered systems. Here we sought academic experts that have worked on the health of fish in aquaculture and precisely the health and breeding of Koi. The ideas generated we had at this stage were based on discussion among ourselves and from a review of the associated literature. We were able to discuss in detail our potential solutions with professors and bring back more ideas for the refinement stage of our project design.
Once we developed our idea and design to an advanced stage we wanted to seek out people within the fish feed and drug industry, as these people are also experts in the final product for therapeutics relating to aquaculture. At this stage we had identified new problems that needed overcoming and got valuable insight from these people on the methods used to deliver such medicines and biomolecules to fish. We also gained insight into the business side of things and how we could possibly eventually develop our idea into a marketable product should any trails we performed prove successful.